The incremental cost of traumatic brain injury during the first year after a road traffic accident.


Journal

Brain injury
ISSN: 1362-301X
Titre abrégé: Brain Inj
Pays: England
ID NLM: 8710358

Informations de publication

Date de publication:
2019
Historique:
pubmed: 13 7 2019
medline: 9 6 2020
entrez: 13 7 2019
Statut: ppublish

Résumé

This study aims to determine the incremental cost of TBI during the first year after a traffic accident, compared to other patients with similar non-TBI injuries. Secondly, identification of factors associated with medical costs of TBI is pursued. Analyses were performed on administrative data for traffic victims hospitalised in Belgium between 2009 and 2011. Medical costs attributable to the accident are estimated over one year post-injury. Cases with TBI were matched to controls with similar non-TBI injuries to determine the incremental cost of TBI. Both aims of this research were assessed using regression analysis. The incremental cost of TBI is estimated to range between € 10 042 (95%CI [€8198; €11 887]) and €21 715 (95%CI [€13 5889; €29 540]). Age, problems with self-reliance, survival status, the occurrence of acute events and severity of TBI are significant predictors of medical costs. As to healthcare utilisation, MRI usage, inpatient rehabilitation facilities, nursing homes and readmissions to acute hospital stand out as having most influence on costs. This study reveals a considerable incremental cost of TBI. Policy-making bodies should be made aware of this phenomenon and a diversified policy should be considered when financing programs are discussed.

Identifiants

pubmed: 31298587
doi: 10.1080/02699052.2019.1641224
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1234-1244

Auteurs

Helena Van Deynse (H)

a Department of Public Health, Interuniversity Centre of Health Economics Research, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel , Brussels , Belgium.

Griet Van Belleghem (G)

a Department of Public Health, Interuniversity Centre of Health Economics Research, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel , Brussels , Belgium.

Door Lauwaert (D)

b Emergency and Disaster Medicine, Department of Emergency Medicine, Universitair Ziekenhuis Brussel , Brussels , Belgium.

Maarten Moens (M)

c Department of Neurosurgery, Universitair Ziekenhuis Brussel , Brussels , Belgium.
d Department of Radiology, Universitair Ziekenhuis Brussel , Brussels , Belgium.

Karen Pien (K)

e Department of Medical Registration, Universitair Ziekenhuis Brussel , Brussels , Belgium.

Stefanie Devos (S)

a Department of Public Health, Interuniversity Centre of Health Economics Research, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel , Brussels , Belgium.

Ives Hubloue (I)

b Emergency and Disaster Medicine, Department of Emergency Medicine, Universitair Ziekenhuis Brussel , Brussels , Belgium.

Koen Putman (K)

a Department of Public Health, Interuniversity Centre of Health Economics Research, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel , Brussels , Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH